RxDoctor Payments Data

Peter Polewski, MD

Hematology & Oncology · Grafton, WINPI 1659784940

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $44 of the $44 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, AstraZeneca. That places this record below the midpoint for hematology & oncology clinicians in WI, where the typical reported total is $411.

$44in general payments, 2019–2025

Across 1 payment — averaging $43.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$44
$103,000in research payments, 2019–2025

Across 17 payments — averaging $6058.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$47K
  • Pfizer$47K
  • AstraZeneca$9K

What the payments were for

  • Travel & lodging$44100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$44

How this compares

$44 in reported general payments places this provider in the 10th percentile of 248 hematology & oncology providers in Wisconsin.

See all hematology & oncology providers in Wisconsin →

Medicare billing

Part B allowed, 2024
$75,789
Medicare patients
256
Services billed
1,069

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide28$530,944
Abiraterone Acetate53$86,007
EliquisApixaban101$67,275
CreonLipase/Protease/Amylase15$17,895
Hydroxyurea77$1,450
Duloxetine Hcl47$784
Dexamethasone69$780
Prochlorperazine Maleate60$694
LoperamideLoperamide Hcl38$518
Potassium Chloride23$503
Anastrozole38$466
Acyclovir37$314
ValacyclovirValacyclovir Hcl11$264
Gabapentin18$263
Allopurinol24$226

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Grafton

See the full list for Wisconsin →

Where these figures come from

Is this you, or does something look wrong? →